These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25749663)

  • 21. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.
    Mann M; Mengistu A; Gaeseb J; Sagwa E; Mazibuko G; Babigumira JB; Garrison LP; Stergachis A
    Drug Saf; 2016 Sep; 39(9):859-72. PubMed ID: 27314405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
    Anwikar SR; Bandekar MS; Smrati B; Pazare AP; Tatke PA; Kshirsagar NA
    Int J Risk Saf Med; 2011; 23(3):163-9. PubMed ID: 22020396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua.
    Lorío M; Colasanti J; Moreira S; Gutierrez G; Quant C
    J Int Assoc Provid AIDS Care; 2014; 13(5):466-70. PubMed ID: 24935691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors.
    Nanyonga SM; Kitutu FE; Kalyango J; Frank M; Kiguba R
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):215-221. PubMed ID: 34693930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.
    Modayil RR; Harugeri A; Parthasarathi G; Ramesh M; Prasad R; Naik V; Giriyapura V
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):247-55. PubMed ID: 20066675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].
    Patrignani A; Palmieri G; Ciampani N; Moretti V; Mariani A; Racca L
    G Ital Cardiol (Rome); 2018 Jan; 19(1):54-61. PubMed ID: 29451510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007 - 2011.
    Dube NM; Summers R; Tint KS; Mayayise G
    Pan Afr Med J; 2012; 11():39. PubMed ID: 22593775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.
    Katusiime B; Semakula D; Lubinga SJ
    Afr Health Sci; 2015 Dec; 15(4):1308-17. PubMed ID: 26958036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire.
    Jaquet A; Djima MM; Coffie P; Kacou HD; Eholie SP; Messou E; Minga A; Guehi C; Yavo JC; Bissagnene E; Dabis F; Ekouevi DK;
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1303-10. PubMed ID: 21735508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
    Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
    Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.
    Mayanja BN; Kasamba I; Levin J; Namakoola I; Kazooba P; Were J; Kaleebu P; Munderi P;
    AIDS Res Ther; 2017; 14():26. PubMed ID: 28484508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits].
    Durrieu G; Jacquot J; Baudrin D; Mège M; Rousseau V; Bagheri H; Bondon-Guitton E; Abadie D; Montastruc F; Bismuth M; Oustric S; Montastruc JL
    Therapie; 2017 Jun; 72(3):351-355. PubMed ID: 27865436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
    Li YY; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient reporting practices of suspected adverse drug reactions to antiretroviral drugs in a tertiary health facility in Nigeria.
    Balogun SH; Adeleye OA
    Niger Postgrad Med J; 2014 Dec; 21(4):331-7. PubMed ID: 25633453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.
    Fornasier G; Taborelli M; Francescon S; Polesel J; Aliberti M; De Paoli P; Baldo P
    Int J Clin Pharm; 2018 Aug; 40(4):795-802. PubMed ID: 29785683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.